Pharma

The objective of the European Directive 2011/62/EU on falsified medical products is to prevent the counterfeiting of prescription and high-risk non-prescription medicines. It includes two requirements, which had to be implemented by February 2019:

1. Pharmaceutical packaging must be marked with an individual serial number to ensure traceability back to the manufacturer.
2. In addition, the packaging must have features that make it easy to detect attempts to tamper by opening the packaging.

A definition of these features is provided by the EU standard EN 16679 “Packaging – Tamper verification features for medicinal product packaging”.

Our products Pharma 404425 and Pharma 404427  are designed to ensure tamper-proof marking on pharmaceutical folding cartons and thus support compliance with the Directive on falsified medicinal products. Security labels ensure that the packaging board tears in a fiber-destroying manner when it is attempted to remove the label which provides clear evidence of the tampering attempt.